Cargando…

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity

Detalles Bibliográficos
Autores principales:	Burgoyne, Adam M., Vann, Kendra R., Joshi, Shweta, Morales, Guillermo A., Vega, Francisco M., Singh, Alok, Pal, Dhananjaya, Merati, Aran B., Kutateladze, Tatiana G., Durden, Donald L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385619/ https://www.ncbi.nlm.nih.gov/pubmed/32793389 http://dx.doi.org/10.1038/s41421-020-0181-z

Ejemplares similares

Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets
por: Vann, Kendra R., et al.
Publicado: (2020)

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma
por: Pal, Dhananjaya, et al.
Publicado: (2021)

Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma
por: Vann, Kendra R., et al.
Publicado: (2022)

Catching BETs by viruses
por: Zandian, Mohamad, et al.
Publicado: (2022)

Inhibition of translation and immune responses by the virulence factor Nsp1 of SARS-CoV-2
por: Vann, Kendra R., et al.
Publicado: (2020)

Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancer
por: Ge, Jennifer Y., et al.
Publicado: (2020)

PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
por: Acharya, Arpan, et al.
Publicado: (2022)

Protocol for Biochemical Analysis and Structure Determination of the ZZ Domain of the E3 Ubiquitin Ligase HERC2
por: Liu, Jiuyang, et al.
Publicado: (2020)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

Epigenetic countermarks in mitotic chromosome condensation
por: van Wely, Karel H. M., et al.
Publicado: (2017)

A PKC-SHP1 signaling axis desensitizes Fcγ receptor signaling by reducing the tyrosine phosphorylation of CBL and regulates FcγR mediated phagocytosis
por: Joshi, Shweta, et al.
Publicado: (2014)

Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model
por: Singh, Alok R, et al.
Publicado: (2014)

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
por: Bolin, Sara, et al.
Publicado: (2018)

Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
por: Mao, Wendy, et al.
Publicado: (2019)

Role of BET Inhibitors in Triple Negative Breast Cancers
por: Khandekar, Durga, et al.
Publicado: (2020)

Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection
por: Vann, Kendra R., et al.
Publicado: (2022)

Combinatorial Approach to Improve Cancer Immunotherapy: Rational Drug Design Strategy to Simultaneously Hit Multiple Targets to Kill Tumor Cells and to Activate the Immune System
por: Joshi, Shweta, et al.
Publicado: (2019)

Multiple myeloma: Combination therapy of BET proteolysis targeting chimeric molecule with CDK9 inhibitor
por: Lim, Su-Lin, et al.
Publicado: (2020)

Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors
por: Elshazly, Ahmed M., et al.
Publicado: (2023)

Response and resistance to BET bromodomain inhibitors in triple negative breast cancer
por: Shu, Shaokun, et al.
Publicado: (2016)

To Bet or Not to Bet on T-bet As a Therapeutic Target in Emphysema?
por: Wang, Xiaoyun, et al.
Publicado: (2019)

BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells
por: Sriha, Jessica, et al.
Publicado: (2022)

Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo
por: Joshi, Shweta, et al.
Publicado: (2014)

Triple-Plane Augmentation Mastopexy
por: Ismail, Karima T., et al.
Publicado: (2019)

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
por: Noblejas-López, María del Mar, et al.
Publicado: (2019)

T-bet(+) lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer
por: Mori, Hitomi, et al.
Publicado: (2019)

BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
por: Baker, Emma K, et al.
Publicado: (2015)

Lifetime Prediction of Polymers: To Bet, or Not to Bet—Is This the Question?
por: Blanco, Ignazio
Publicado: (2018)

The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection
por: Dominguez, Claudia X., et al.
Publicado: (2015)

The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer
por: Miller, Aubrey L., et al.
Publicado: (2021)

The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
por: Gerlach, Daniel, et al.
Publicado: (2018)

Rac2 is required for alternative macrophage activation and bleomycin induced pulmonary fibrosis; a macrophage autonomous phenotype
por: Joshi, Shweta, et al.
Publicado: (2017)

Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer
por: Park, In Hae, et al.
Publicado: (2019)

Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion
por: Zhang, Yi, et al.
Publicado: (2020)

CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer
por: Zeng, Siyuan, et al.
Publicado: (2022)

Learning Not to Bet
por: Seager, Philip
Publicado: (1969)

Combining CDK4/6 inhibitors ribociclib and palbociclib with cytotoxic agents does not enhance cytotoxicity
por: Jin, Dan, et al.
Publicado: (2019)

BET inhibitors: Betting on improved outcomes in uterine serous carcinoma
por: Zeybek, Burak, et al.
Publicado: (2018)

Bet‐hedging and best‐bet strategies shape seed dormancy
por: Pausas, Juli G., et al.
Publicado: (2022)

Determinants of problem sports betting among college students: moderating roles of betting frequency and impulsive betting tendency
por: Shen, Yawen
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d9t3nlb5l5kiv39s478vnhvr3s